Publications by authors named "Lars Asphaug"

Claim this Profile
E
Effects of Prophylactic Oxytocin or Carbetocin on Troponin Release and Postpartum Haemorrhage at Planned Caesarean Delivery: A Double-Blind Randomised Controlled Trial.
Maria E Bekkenes, Marte M Jørgensen, Anne F Jacobsen, Morten W Fagerland, Helene Rakstad-Larsen, Lars Asphaug

BJOG· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Response.
Maria E Bekkenes, Marte M Jørgensen, Anne F Jacobsen, Morten W Fagerland, Helene Rakstad-Larsen, Lars Asphaug

BJOG· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of Prosigna for Adjuvant Treatment Decisions in Early Breast Cancer: Healthcare Sector and Societal Perspectives.
Lars Asphaug, Lars A Akslen, Egil S Blix, Beate Boge, Elin F Borgen

Clin Breast Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Occupational therapist-led versus rheumatologist-led care in people with hand osteoarthritis in Norway: an open-label, multicentre, randomised controlled, non-inferiority trial.
Annikka Polster, Unni Olsen, Lars Asphaug, Kjetil Bergsmark, Barbara Christensen

Lancet Rheumatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protocol of a randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with non-metastatic high-risk prostate cancer (SPCG 19/GRand-P).
Sven Löffeler, Helena Bertilsson, Christoph Müller, Kirsti Aas, Hege Sagstuen Haugnes, Lars Asphaug

BJU Int· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of a psychosocial web-based intervention for adolescents distressed by a visible difference: Results from a randomized controlled trial in Norway.
Johanna Kling, Lars Asphaug, Kristin B Feragen

Scand J Psychol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating survival, quality of life and cognition in PROton versus photon therapy for mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden.
Liv Cathrine Heggebø, Ida Maria Henriksen Borgen, Hillevi Rylander, Cecilie Kiserud, Tonje Haug Nordenmark, Lars Asphaug

BMJ Open· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Noninvasive Screening for Alcohol-Related Liver Fibrosis.
Lars Asphaug, Maja Thiele, Aleksander Krag, Hans Olav Melberg

Hepatology· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Cost-Effectiveness of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer in Norway.
Lars Asphaug, Hans Olav Melberg

MDM Policy Pract· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis